Evotec SE (0IRF.L)
LSE - LSE Delayed price. Currency in EUR
Add to watchlist
At close: 06:18PM BST
| Previous close | 25.44 |
| Open | 25.15 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 25.12 - 25.74 |
| 52-week range | 14.81 - 25.74 |
| Volume | |
| Avg. volume | 179,314 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Evotec SE (ETR:EVT) Yearly Results: Here's What Analysts Are Forecasting For This Year
One of the biggest stories of last week was how Evotec SE ( ETR:EVT ) shares plunged 32% in the week since its latest...
Simply Wall St.Evotec Full Year 2023 Earnings: EPS Misses Expectations
Evotec ( ETR:EVT ) Full Year 2023 Results Key Financial Results Revenue: €781.4m (up 4.0% from FY 2022). Net loss...
PR NewswireEVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Variant Bio, Inc. today announced a collaboration agreement to identify a best-in-class treatment for diseases caused by fibrosis.
© 2024 Yahoo. All rights reserved.